Friday, July 10, 2026

pharma · Systemic Lupus Erythematosus · Lupus Erythematosus, Systemic

Serana Europe

Serana Europe patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Pessin, DE HQ
2014 Founded
20 Employees
EMA registrant Type
Company details
Status
Public
HQ
Pessin, DE
Founded
2014
Employees
20
Programs
8
Drugs
8
Patents
0
Intelligence · Patents

Serana Europe patents

0 pharmaceutical patents indexed for Serana Europe. 0 expire within 24 months.

Serana Europe has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does Serana Europe have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Serana Europe patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.